[1] [1] D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies[J]. J Hepatol, 2006, 44(1): 217-231.

[2] [2] D'Amico G, Pasta L, Morabito A, et al. Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients[J]. Aliment Pharmacol Ther, 2014, 39(10): 1180-1193.

[3] [3] Bruno S, Saibeni S, Bagnardi V, et al. Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients: a nationwide, prospective, 3-year follow-up study in Italy[J]. Am J Gastroenterol, 2013, 108(7): 1112-1122.

[4] [4] Reverter E, Tandon P, Augustin S, et al. A MELD-based model to determine risk of mortality among patients with acute variceal bleeding[J]. Gastroenterology, 2014, 146(2): 412-419. e3.

[5] [5] Tapper EB, Friderici J, Borman ZA, et al. A multicenter evaluation of adherence to 4 major elements of the Baveno guidelines and outcomes for patients with acute variceal hemorrhage[J]. J Clin Gastroenterol, 2018, 52(2): 172-177.

[6] [6] Augustin S, Muntaner L, Altamirano JT, et al. Predicting early mortality after acute variceal hemorrhage based on classification and regression tree analysis[J]. Clin Gastroenterol Hepatol, 2009, 7(12): 1347-1354.

[7] [7] Ashkenazi E, Kovalev Y, Zuckerman E. Evaluation and treatment of esophageal varices in the cirrhotic patient[J]. Isr Med Assoc J, 2013, 15(2): 109-115.

[8] [8] Berzigotti A, Seijo S, Arena U, et al. Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis[J]. Gastroenterology, 2013, 144(1): 102-111. e1.

[9] [9] Wong GLH, Kwok R, Hui AJ, et al. A new screening strategy for varices by liver and spleen stiffness measurement (LSSM) in cirrhotic patients: A randomized trial[J]. Liver Int, 2018, 38(4): 636-644.

[10] [10] Stefanescu H, Marasco G, Cals P, et al. A novel spleen-dedicated stiffness measurement by FibroScan® improves the screening of high-risk oesophageal varices[J]. Liver Int, 2020, 40(1): 175-185.

[11] [11] Manatsathit W, Samant H, Kapur S, et al. Accuracy of liver stiffness, spleen stiffness, and LS-spleen diameter to platelet ratio score in detection of esophageal varices: Systemic review and meta-analysis[J]. J Gastroenterol Hepatol, 2018, 33(10): 1696-1706.

[12] [12] Li S, Huang P, Jeyarajan AJ, et al. Assessment of non-invasive markers for the prediction of esophageal variceal hemorrhage[J]. Front Med (Lausanne), 2021, 8: 770836.

[13] [13] Huang TH, Lin MT, Wang JH, et al. Clinical and novel application of FibroScan, FIB-4 and aspartate aminotransferase-to-platelet ratio index in liver fibrosis evaluation in patients with hepatocellular carcinoma and their roles in oesophageal variceal prediction[J]. Int J Clin Pract, 2021, 75(4): e13945.

[14] [14] Ayonrinde OT, Zelesco M, Welman CJ, et al. Clinical relevance of shear wave elastography compared with transient elastography and other markers of liver fibrosis[J]. Intern Med J, 2022, 52(4): 640-650.

[15] [15] Bolognesi M, Di Pascoli M, Sacerdoti D. Clinical role of non-invasive assessment of portal hypertension[J]. World J Gastroenterol, 2017, 23(1): 1-10.

[16] [16] Hu X, Liu W, Liu J, et al. Research advances in serum chitinase-3-like protein 1 in liver fibrosis[J]. Front Med (Lausanne), 2024, 11: 1372434.

[18] [18] Qiu H, Zhang X. The value of serum CHI3L1 for the diagnosis of chronic liver diseases[J]. Int J Gen Med, 2022, 15: 5835-5841.

[19] [19] Hu P, Miao H, Li M, et al. Identification of plasma biomarkers for non-invasive diagnosis of hepatitis B cirrhosis[J]. J Pharm Biomed Anal, 2025, 263: 116909.

[21] [21] Liu H, Chen P, Jiang B, et al. The value of platelet parameters and related scoring system in predicting esophageal varices and collateral veins in patients with liver cirrhosis[J]. J Clin Lab Anal, 2021, 35(3): e23694.

[22] [22] Wang B, Zhou J, Wu X, et al. Screening varices in patients with HBV-related cirrhosis on antiviral therapy: Platelet alone or together with LSM[J]. Liver Int, 2021, 41(2): 369-377.

[23] [23] de Franchis R, BavenoⅥ Faculty. Expanding consensus in portal hypertension: Report of the BavenoⅥ Consensus Workshop: Stratifying risk and individualizing care for portal hypertension[J]. J Hepatol, 2015, 63(3): 743-752.

[24] [24] Jhang ZE, Wu KL, Chen CB, et al. Diagnostic value of spleen stiffness by magnetic resonance elastography for prediction of esophageal varices in cirrhotic patients[J]. Abdom Radiol (NY), 2021, 46(2): 526-533.

[25] [25] Fofiu R, Bende F, Popescu A, et al. Spleen and liver stiffness for predicting high-risk varices in patients with compensated liver cirrhosis[J]. Ultrasound Med Biol, 2021, 47(1): 76-83.

[27] [27] Berzigotti A. Non-invasive evaluation of portal hypertension using ultrasound elastography[J]. J Hepatol, 2017, 67(2): 399-411.